Key result
Carotid intraplaque neovascularization intensity is linked to ~47% greater coronary plaque vulnerability in CAD.
Why the study?
The study evaluated relationships between carotid intraplaque neovascularization measured by contrast-enhanced ultrasound and culprit coronary artery plaque vulnerability evaluated by optical coherence tomography in patients with CAD.
Does carotid intraplaque neovascularization measured by CEUS correlate with coronary plaque vulnerability detected by OCT in patients with CAD?
Observational (n=131)
Does carotid intraplaque neovascularization measured by CEUS correlate with coronary plaque vulnerability detected by OCT in patients with CAD?
Odds Ratio: 1.473 (95% CI 1.039–2.086)
Carotid intraplaque neovascularization parameters measured by non-invasive contrast-enhanced ultrasound significantly correlate with coronary plaque vulnerability, offering a potential tool for advanced risk stratification in CAD patients.
May support carotid CEUS for CAD risk stratification; hypothesis-generating and should not yet change practice.
OBJECTIVE: The aim of the present study was to evaluate the relationships between carotid intraplaque neovascularization (IPN) measured by contrast-enhanced ultrasound (CEUS) and culprit coronary artery plaque vulnerability evaluated by optical coherence tomography (OCT) in patients with coronary artery disease (CAD). METHODS: A total of 131 participants were divided into the vulnerable coronary plaque (VP) and non-vulnerable coronary plaque (non-VP) group. The plaque vulnerability was determined by OCT. In CEUS, carotid IPN was assessed by semi-quantitative and quantitative evaluation, the carotid plaque with the maximum plaque height (MPH) was used for analysis. Logistic regression was used to assess risk factors of coronary plaque vulnerability. RESULTS: Patients were classified into VP group (N = 92) and non-VP group (N = 39) according to the features of plaque vulnerability in OCT. In CEUS, the IPN score between the two groups was significant different(P = 0.003). Quantitative analysis of CEUS showed that carotid plaque peak intensity (PI) (28.65 ± 4.21 dB vs. 22.51 ± 3.13 dB, P < 0.001), enhancement intensity (EI) (24.91 ± 4.05 dB vs. 19.20 ± 3.17 dB, P < 0.001), and enhanced intensity ratio of plaque/lumen (P/L ratio) (0.32 ± 0.08 vs. 0.24 ± 0.09, P < 0.001) were higher in VP group than non-VP group. Multivariate logistic regression analyses demonstrated that EI (OR = 1.473, 95 %CI: (1.039-2.086)) and P/L ratio (OR = 1.109, 95 %CI: (1.024-1.2)) were strongly associated with coronary plaque vulnerability. CONCLUSION: The CEUS parameters of carotid plaques is correlated with coronary plaque vulnerability. As a non-invasive examination, CEUS may provide valuable information to advance risk stratification and clinical treatment in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted an observational in Coronary artery disease (n=131). Carotid intraplaque neovascularization (IPN) vs. Lower intraplaque neovascularization was evaluated on Coronary plaque vulnerability (OR 1.473, 95% CI 1.039-2.086). Carotid intraplaque neovascularization enhancement intensity was strongly associated with coronary plaque vulnerability in patients with CAD (OR 1.473; 95% CI 1.039-2.086).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: